Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|46|5|1548-1563

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.46, Iss.5, 2007-11, pp. : 1548-1563

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amino Acid Substitution in HCV Core Region and Genetic Variation near the IL28B Gene Affect Viral Dynamics during Telaprevir, Peginterferon and Ribavirin Treatment

By  

Intervirology, Vol. 55, Iss. 6, 2012-06 ,pp. : 417-425

Karger

Access to resources Recommend Favorite

Y. S. Sakin et al.

By  

HEPATOLOGY RESEARCH, Vol. 44, Iss. 9, 2014-09 ,pp. : 1037-1037

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-effectiveness of peginterferon alfa-2b in combination with ribavirin as initial treatment for chronic hepatitis C in Sweden

By Bernfort Lars   Sennfält Karin   Reichard Olle  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 6-7, 2006-07 ,pp. : 497-505

Informa Healthcare

Access to resources Recommend Favorite

Undetectable HCV‐RNA at treatment‐week 8 results in high‐sustained virological response in HCV G1 treatment‐experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 5, 2015-05 ,pp. : 469-480

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatic Gene Expression Response to Acute Indomethacin Exposure

By LaFramboise William A.   Bombach Kelly L.  

Molecular Diagnosis & Therapy, Vol. 10, Iss. 3, 2006-01 ,pp. : 187-196

Adis International

Access to resources Recommend Favorite